Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.5237
H.R.5237: Reduced Costs and Continued Cures Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Sept. 10, 2021
- Latest Major Action Nov. 1, 2022
Bill Sponsor
Bill Cosponsors
4 (All Democrats)
Bill Version
- Introduced in House - Sept. 10, 2021
Bill Summary
Reduced Costs and Continued Cures Act of 2021 This bill establishes and alters several programs and requirements relating to the prices of prescription drugs. For example, the bill establishes and alters several requirements under Medicare and Medicaid, including requiring drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Nov. 1, 2022 |
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
|
Nov. 1, 2022 |
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
|
Sept. 13, 2021 |
Referred to the Subcommittee on Health.
|
Sept. 10, 2021 |
Referred to the Subcommittee on Health.
|
Sept. 10, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Sept. 10, 2021 |
Introduced in the House by Scott Peters (D-Calif.) |